Sennato, S.; Paldino, G.; Bombelli, C.; Mezzani, I.; Petrini, S.; Delfino, D.V.; Fiorentino, F.; Marianecci, C.; Ciogli, A.; Rotili, D.;
et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710.
https://doi.org/10.3390/pharmaceutics17060710
AMA Style
Sennato S, Paldino G, Bombelli C, Mezzani I, Petrini S, Delfino DV, Fiorentino F, Marianecci C, Ciogli A, Rotili D,
et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics. 2025; 17(6):710.
https://doi.org/10.3390/pharmaceutics17060710
Chicago/Turabian Style
Sennato, Simona, Giorgia Paldino, Cecilia Bombelli, Irene Mezzani, Stefania Petrini, Domenico Vittorio Delfino, Francesco Fiorentino, Carlotta Marianecci, Alessia Ciogli, Dante Rotili,
and et al. 2025. "Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity" Pharmaceutics 17, no. 6: 710.
https://doi.org/10.3390/pharmaceutics17060710
APA Style
Sennato, S., Paldino, G., Bombelli, C., Mezzani, I., Petrini, S., Delfino, D. V., Fiorentino, F., Marianecci, C., Ciogli, A., Rotili, D., Ceccacci, F., & Fierabracci, A.
(2025). Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics, 17(6), 710.
https://doi.org/10.3390/pharmaceutics17060710
